Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase

Farnesyltransferase inhibitors (FTIs) are focus for the treatment of several diseases, particularly in the field of cancer therapy. Their potential, however, goes even further, as a number of studies have evaluated FTIs for the treatment of infectious diseases such as malaria, African sleeping sickn...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lea Weber, Anna Hagemann, Jila Kaltenhäuser, Manuela Besser, Patrick Rockenfeller, Anja Ehrhardt, Ewa Stuermer, Hagen Sjard Bachmann
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/a3e8589be9a54fd8be8389b29ac75ab9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!